Sue Sha - Concepedia

Author

Sue Sha

Janssen (United States)

Also Known As

S. G. Sha, S. Sha, Sue Sha, Z. Morrison

Publications

Citations

H-Index

Concepts

All Affiliations

Janssen (United States)Profil Institute for Metabolic Research Janssen (Belgium)University of California San Diego Johnson & Johnson (United States)

About

Sue Sha is an author at Janssen (United States) specializing in medicine, pharmacology, and drug safety.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	183
2	Health Sciences	1	1	125
3	Diabetes	1	1	125
4	Gastroenterology	1	1	125
5	Hepatology	1	1	125

Sue Sha

Publications

1.7K

Citations

H-Index

Page 1

	Year	Citations
Canagliflozin, a novel inhibitor of sodium glucose co‐transporter 2, dose dependently reduces calculated renal threshold for glucose excretion and increases urinary glucose excretion in healthy subjects Sue Sha, Damayanthi Devineni, A. Ghosh, Diabetes Obesity and Metabolism	2011	292
Canagliflozin Lowers Postprandial Glucose and Insulin by Delaying Intestinal Glucose Absorption in Addition to Increasing Urinary Glucose Excretion David Polidori, Sue Sha, Sunder Mudaliar, Diabetes Care	2013	259
Effect of the sodium glucose co‐transporter 2 inhibitor canagliflozin on plasma volume in patients with type 2 diabetes mellitus Sue Sha, David Polidori, Tim Heise, Diabetes Obesity and Metabolism	2014	235
Effect of canagliflozin treatment on hepatic triglyceride content and glucose metabolism in patients with type 2 diabetes Kenneth Cusi, Fernando Bril, Diana Barb, Diabetes Obesity and Metabolism	2018	191
Time-Action Profile of Inhaled Insulin in Comparison With Subcutaneously Injected Insulin Lispro and Regular Human Insulin Klaus Rave, S. Bott, Lutz Heinemann, Diabetes Care	2005	171
Effect of canagliflozin on liver function tests in patients with type 2 diabetes Lawrence A. Leiter, Thomas Först, David Polidori, Diabetes & Metabolism Metabolic SyndromeDiabetes ManagementHepatologyLiver PhysiologyDiabetes	2015	125
Pharmacodynamic differences between canagliflozin and dapagliflozin: results of a randomized, double‐blind, crossover study Sue Sha, David Polidori, Kristin Farrell, Diabetes Obesity and Metabolism	2014	90
Validation of a Novel Method for Determining the Renal Threshold for Glucose Excretion in Untreated and Canagliflozin-treated Subjects With Type 2 Diabetes Mellitus David Polidori, Sue Sha, Atalanta Ghosh, The Journal of Clinical Endocrinology & Metabolism	2013	87
The Effect of Smoking Cessation and Subsequent Resumption on Absorption of Inhaled Insulin R. H. A. Becker, Sue Sha, Annke Frick, Diabetes Care	2006	76
Metabolism and Excretion of Canagliflozin in Mice, Rats, Dogs, and Humans Rao N. V. S. Mamidi, Filip Cuyckens, Jie Chen, Drug Metabolism and Disposition	2014	63

Page 1